ClinicalTrials.gg
Enrolling by invitationNCT07772973ROTATEUpdated Aug 19, 2026

Comparison of Two Mechanical Rotation Chairs With Diagnostics of Benign Paroxysmal Positional Vertigo.

An observational study in Benign Paroxysmal Positional Vertigo (BPPV), sponsored by Aalborg University Hospital. Enrolling by invitation at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-19.

Sponsored by Aalborg University Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to investigate whether the diagnosis of benign paroxysmal positional vertigo (BPPV) is equally good with two different mechanical rotation chairs (MRCs) (TRV rotary chair and the Rotundum rotary chair). In the study, two different diagnostic criteria will be used (the international Bárány criteria and the American Academy of Otolaryngology-Head and Neck surgery (AAO-HNS) criteria) with both MRCs.

Patients with BPPV experience brief attacks of positional vertigo. Typically, this vertigo is provoked by changes in head position relative to gravity, e.g. laying down or turning to the side from the supine position.

Previous studies on the use of MRCs have shown that MRCs offer very precise and accurate BPPV diagnostics. With MRCs it is possible to determine 1) laterality (left/right), 2) specific location (specific semicircular canal), and 3) BPPV subtype (canalolithiasis/cupulolithiasis). Treatment-wise, these MRCs have also shown to be very efficient with treatment success rates being above ninety percent. The two MRCs used in this study do not offer the exact same features (e.g. design, portability, fixed positions, and the possibility of adding kinetic energy). To the knowledge of the authors, no studies exist on direct comparison of separate MRCs. The Rotundum rotary chair, which is also the newest of the two MRCs included, has so far not been included in many studies. However, the hypothesis of the current study is that the Rotundum rotary chair and the TRV rotation chair are equally good in terms of BPPV diagnostics.

Read the detailed description

The primary aim is to investigate whether diagnostics of benign paroxysmal positional vertigo (BPPV) is equally good with two different MRCs, using both the international Bárány Society criteria and the American AAO-HNS criteria with both MRCs. Whether or not these two MRCs may be considered equally good will be evaluated based on the number of identified BPPV cases with each MRC as well as laterality (right/left), semicircular canal location (anterior/posterior/lateral) and subtype of BPPV (canalithiasis/cupulolithiasis). The participants in this study are patients with a typical BPPV history that have been referred to a University Hospital based tertiary dizziness outpatient clinic.

The following mechanical rotation chairs will be used:

  • TRV® rotary chair (Interacoustics©, Middelfart, Danmark).
  • Rotundum® rotary chair (balcare GmbH©, Küsnacht, Schweiz).

With MRC testing, advanced videonystagmography (VNG) glasses are used to visualize, monitor, and register eye movements. With the TRV chair, VF405® (Interacoustics©, Middelfart, Denmark) will be used with the software Micromedical VisualEyes™ (version 3.1.0.203, Interacoustics©, Middelfart, Denmark). With the Rotundum chair, the ICS Impulse® (Natus Inc©, Middleton, WA, USA) will be used with the software OTOsuite (4.88®, Natus Inc©, Middleton, WA, USA).

The same diagnostic procedure will be performed with each MRC. This includes the supine position, bilateral supine roll tests (SRTs), bilateral Dix-Hallpike tests, and, if lateral canal BPPV is ambigious, the bow and lean test. Initial MRC will be randomized.

For each participant, the following data will be collected:

  • Age
  • Gender
  • Type and duration of symptoms
  • Description of nystagmus (direction, duration, a-SPV, latency)
  • Subjective vertigo during tests
  • Description of BPPV (laterality, semicircular canal localization, subtype)

Sample size assessment Data will be analyzed using Cohen's Kappa. A dropout rate of 10 percent and a power of 90 percent is expected.

02

Conditions studied

  • Benign Paroxysmal Positional Vertigo (BPPV)

Keywords

  • Benign Paroxysmal Positional Vertigo
  • BPPV
  • Mechanical Rotation Chair
  • Rotundum rotary chair
  • TRV chair
  • Vertigo
03

In context

Benign Paroxysmal Positional Vertigo

75 studies on the registry are indexed under Benign Paroxysmal Positional Vertigo; 15 are open to participants now.

This study's planned enrollment of 200 is above the median of 104 across 11 observational studies indexed under Benign Paroxysmal Positional Vertigo.

Browse Benign Paroxysmal Positional Vertigo studies →

Lead sponsor

Aalborg University Hospital is the lead sponsor of 198 studies on the registry; 41 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Subjects are referred by their general practitioner or from a private ENT on the basis of a typical BPPV case history and/or clinical findings suggesting the presence of BPPV to examination in a rotation chair at the investigational site.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ≥ 18 years of age
  • Typical BPPV history

Exclusion criteria

Exclusion Criteria:

  • Unable to comply with full diagnostic procedure in TRV and Rotundum rotary chair
  • Intake of 1st generation antihistamines within the last 7 days
  • Intake of benzodiazepines within the last 7 days
  • Known cerebral aneurysm
  • Recent cerebral hemorrhagia
  • Weight > 150 kg
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200 participants (estimated)
Patient registry
No

Groups and cohorts

  • TRV chair - Bárány Criteria

    A group of participants with suspected BPPV who undergo a diagnostic procedure for BPPV in the TRV chair. The diagnosis, laterality, semicircular canal localization, and subtypes in this group are determined according to the diagnostic criteria published by the Bárány Society.

    Device: TRV® (Interacoustics©, Middelfart, Denmark), mechanical rotational chair

  • Rotundum chair - Bárány Criteria

    A group of participants with suspected BPPV who undergo a diagnostic procedure for BPPV in the Rotundum chair. The diagnosis, laterality, semicircular canal localization, and subtypes in this group are determined according to the diagnostic criteria published by the Bárány Society.

    Device: Rotundum® (balcare GmbH©, Küsnacht, Switzerland), mechanical rotational chair.

  • TRV chair - AAO-HNS Criteria

    A group of participants with suspected BPPV who undergo a diagnostic procedure for BPPV in the TRV chair. The diagnosis, laterality, semicircular canal localization, and subtypes in this group are determined according to the diagnostic AAO-HNS criteria.

    Device: TRV® (Interacoustics©, Middelfart, Denmark), mechanical rotational chair

  • Rotundum chair - AAO-HNS Criteria

    A group of participants with suspected BPPV who undergo a diagnostic procedure for BPPV in the Rotundum chair. The diagnosis, laterality, semicircular canal localization, and subtypes in this group are determined according to the diagnostic AAO-HNS criteria.

    Device: Rotundum® (balcare GmbH©, Küsnacht, Switzerland), mechanical rotational chair.

Interventions

  • DeviceTRV® (Interacoustics©, Middelfart, Denmark), mechanical rotational chair

    Diagnostic positioning maneuvers performed using the TRV® MRC to evaluate the presence, affected semicircular canal, and subtype of Benign Paroxysmal Positional Vertigo.

  • DeviceRotundum® (balcare GmbH©, Küsnacht, Switzerland), mechanical rotational chair.

    Diagnostic positioning maneuvers performed using the Rotundum® MRC to evaluate the presence, affected semicircular canal, and subtype of Benign Paroxysmal Positional Vertigo.

06

What researchers measure

Primary outcomes

  1. Difference in the ability to diagnose BPPV

    Statistically significant difference in the ability to induce nystagmus and/or vertigo between the TRV chair and Rotundum chair.

    Time frame: 40 minutes

  2. Agreement on the diagnosis of BPPV in individual semicircular canals and subtype of BPPV

    Statistically significant difference in the ability to induce nystagmus and/or vertigo between the TRV chair and Rotundum chair for each individual semicircular canal and for subtype of BPPV i.e. canalolithiasis or cupulolithiasis.

    Time frame: 40 minutes

07

Study locations

1 site
  • Department of Otorhinolaryngology, Head & Neck Surgery and Audiology
    Aalborg, North Jutland 9000, Denmark
08

References and documents

Publications

  • Krzywdzinska S, Rozbicki P, Usowski J, Jurkiewicz D. The use and effectiveness of the TRV Chair - a literature review. Otolaryngol Pol. 2023 Dec 31;77(6):31-36. doi: 10.5604/01.3001.0054.0942. PubMed 38706261 ↗
  • Pedersen MF, Eriksen HH, Kjaersgaard JB, Abrahamsen ER, Hougaard DD. Treatment of Benign Paroxysmal Positional Vertigo with the TRV Reposition Chair. J Int Adv Otol. 2020 Aug;16(2):176-182. doi: 10.5152/iao.2020.6320. PubMed 32784154 ↗
  • Abdulovski S, Klokker M. Repositioning Chairs in the Diagnosis and Treatment of Benign Paroxysmal Positional Vertigo - A Systematic Review. J Int Adv Otol. 2021 Jul;17(4):353-360. doi: 10.5152/iao.2021.9434. PubMed 34309558 ↗
  • Hougaard DD, Duch K, Bech MW. Treatment of posterior Benign Paroxysmal Positional Vertigo is efficient and safe with a new Mechanical Rotational Chair. Front Neurol. 2023 Aug 17;14:1239959. doi: 10.3389/fneur.2023.1239959. eCollection 2023. PubMed 37662040 ↗
  • Hougaard DD, Valsted SH, Bruun NH, Bech MW, Talebnasab MH. Seven years of experience with treatment of benign paroxysmal positional vertigo with a mechanical rotational chair. Front Neurol. 2022 Aug 25;13:981216. doi: 10.3389/fneur.2022.981216. eCollection 2022. PubMed 36090886 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Sep 2026; primary completion for Dec 2026, 3 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 14, 2026
First posted
Aug 19, 2026
StartEst.
Sep 1, 2026
Primary completionEst.
Dec 1, 2026
CompletionEst.
Jan 1, 2027
Last update
Aug 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07772973
Responsible party
Dan Dupont Hougaard (Chief Physician and Associate Professor, Aalborg University Hospital) — Principal investigator
First posted
Aug 19, 2026
Start date
Sep 1, 2026 (estimated)
Primary completion
Dec 1, 2026 (estimated)
Completion
Jan 1, 2027 (estimated)
Last update
Aug 19, 2026

Study contacts

Lucas Toft, BSc in Medicine
study director · Aalborg University
Jakob M Vandbaek, BSc in Medicine
study director · Aalborg University
Fredrik Lund, BSc in Medicine
study director · Aalborg University
Dan D Hougaard, Medical Doctor
study director · Department of Otorhinolaryngology, Head & Neck Surgery and Audiology

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion